| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |